Lori McNeill - 25 Sep 2022 Form 3 Insider Report for Sonnet BioTherapeutics Holdings, Inc. (SONN)

Role: Director
Signature: /s/ John Harry Cross III, Attorney-in-Fact
Issuer symbol: SONN
Transactions as of: 25 Sep 2022
Net transactions value: $0
Form type: 3
Filing time: 04 Oct 2022, 16:30:38 UTC
Next filing: 22 Dec 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24- Power of Attorney